Vasculitis & polymyalgia rheumatica

Gastrointestinal lesions of eosinophilic granulomatosis with polyangiitis: a prediction model and clinical patterns

Arthritis Res TherPublished Retrospective cohort study

Authors' conclusion

Severe gastrointestinal lesions are common in EGPA and early detection is critical. Eosinophils are an important factor associated with gastrointestinal involvement of EGPA. We developed a model to predict the risk of gastrointestinal lesions.

Study context

Population
Patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Participants
165 patients
Exposure
EGPA with vs without gastrointestinal lesions
  • Gastrointestinal lesionsn = 52
  • Severe gastrointestinal lesionsn = 22
Outcome
Predictive model for gastrointestinal lesions in EGPA
Methodological detailsmultivariate logistic regression, nomogram
  • Multivariate logistic regression
  • Nomogram

Main finding

As reported in the abstract

Gastrointestinal lesions

Patients with gastrointestinal lesions

52

Developed severe disorders

22

Eosinophil ratio identifying GI lesions

over 19.2%

Observational data: associations, not effects.

Further findings

Common GI manifestations

Abdominal pain
78%
Diarrhea
40.4%
Nausea and/or vomiting
32.7%

Severe GI lesions

Hemorrhage
26.9%
Ulcers
17.3%
Obstruction
9.6%
Pancreatitis
5.8%

Features of severe GI lesions

Shorter duration from initial symptoms to EGPA diagnosis, less frequent asthma and ear-nose-throat involvement, more likely to receive methylprednisolone pulse

Five Factor Score ≥ 2

Significantly more patients with GI involvement had a Five Factor Score ≥ 2

Clinical patterns

Five well-defined clinical models identified, including the brain-gut pattern

Original publication

Gastrointestinal lesions of eosinophilic granulomatosis with polyangiitis: a prediction model and clinical patterns. Arthritis Res Ther. Published 4 January 2025. doi:10.1186/s13075-024-03467-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.